About Cytiva
PURIDIFY WAS ACQUIRED BY GE HEALTHCARE, NOW CYTIVA IN 2017
Global demand for cheaper biotherapeutics drives the need for bioprocessing cost reduction, a significant proportion of which comes from chromatography reagents and their operation.
• Puridify uses nanofibre technology to create purification solutions for biotherapeutic manufacturing.
• Puridify's chromatography reagent, FibroSelect, reduces bioprocessing costs for manufacturers.
• FibroSelect offers substantial productivity increase in purification whilst making minimal changes to current best practice.
- Focus : Manufacturer
- Industry : Biotechnology
Cytiva Products in the Spotlight
Product portfolio of Cytiva
Similar companies
News about Cytiva
Here you will find Cytiva Netherlands BV
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
